eprintid: 10032311
rev_number: 41
eprint_status: archive
userid: 608
dir: disk0/10/03/23/11
datestamp: 2017-11-08 10:53:28
lastmod: 2021-09-17 22:14:43
status_changed: 2018-03-13 11:53:40
type: article
metadata_visibility: show
creators_name: Jinnah, HA
creators_name: Albanese, A
creators_name: Bhatia, KP
creators_name: Cardoso, F
creators_name: Da Prat, G
creators_name: de Koning, TJ
creators_name: Espay, AJ
creators_name: Fung, V
creators_name: Garcia-Ruiz, PJ
creators_name: Gershanik, O
creators_name: Jankovic, J
creators_name: Kaji, R
creators_name: Kotschet, K
creators_name: Marras, C
creators_name: Miyasaki, JM
creators_name: Morgante, F
creators_name: Munchau, A
creators_name: Pal, PK
creators_name: Rodriguez Oroz, MC
creators_name: Rodriguez-Violante, M
creators_name: Schoels, L
creators_name: Stamelou, M
creators_name: Tijssen, M
creators_name: Uribe Roca, C
creators_name: de la Cerda, A
creators_name: Gatto, EM
title: Treatable Inherited Rare Movement Disorders
ispublished: pub
divisions: UCL
divisions: B02
divisions: C07
divisions: D07
divisions: F84
divisions: F85
keywords: Science & Technology, Life Sciences & Biomedicine, Clinical Neurology, Neurosciences & Neurology, Rare disease, orphan disease, inherited disease, treatment, experimental therapeutics, GLUT1 DEFICIENCY SYNDROME, SYRUP-URINE-DISEASE, ACIDURIA TYPE-I, ATAXIA-TELANGIECTASIA, DIAGNOSTIC-APPROACH, CLINICAL-TRIALS, HYDROXYLASE DEFICIENCY, NEUROLOGICAL DISORDERS, REDUCTASE DEFICIENCY, METABOLIC DISEASE
note: This version is the version of record. For information on re-use, please refer to the publisher’s terms and conditions.
abstract: There are many rare movement disorders, and new ones are described every year. Because they are not well recognized, they often go undiagnosed for long periods of time. However, early diagnosis is becoming increasingly important. Rapid advances in our understanding of the biological mechanisms responsible for many rare disorders have enabled the development of specific treatments for some of them. Well-known historical examples include Wilson disease and dopa-responsive dystonia, for which specific and highly effective treatments have life-altering effects. In recent years, similarly specific and effective treatments have been developed for more than 30 rare inherited movement disorders. These treatments include specific medications, dietary changes, avoidance or management of certain triggers, enzyme replacement therapy, and others. This list of treatable rare movement disorders is likely to grow during the next few years because a number of additional promising treatments are actively being developed or evaluated in clinical trials.
date: 2017-09-01
date_type: published
publisher: WILEY
official_url: https://doi.org/10.1002/mds.27140
full_text_type: pub
language: eng
article_type_text: Review
verified: verified_manual
elements_id: 1418005
doi: 10.1002/mds.27140
lyricists_name: Bhatia, Kailash
lyricists_name: Stamelou, Maria
lyricists_id: KPBHA96
lyricists_id: MSTAM90
actors_name: Stacey, Thomas
actors_id: TSSTA20
actors_role: owner
full_text_status: restricted
publication: Movement Disorders
volume: 33
number: 1
pagerange: 21-35
pages: 15
issn: 1531-8257
citation:        Jinnah, HA;    Albanese, A;    Bhatia, KP;    Cardoso, F;    Da Prat, G;    de Koning, TJ;    Espay, AJ;                                                                             ... Gatto, EM; + view all <#>        Jinnah, HA;  Albanese, A;  Bhatia, KP;  Cardoso, F;  Da Prat, G;  de Koning, TJ;  Espay, AJ;  Fung, V;  Garcia-Ruiz, PJ;  Gershanik, O;  Jankovic, J;  Kaji, R;  Kotschet, K;  Marras, C;  Miyasaki, JM;  Morgante, F;  Munchau, A;  Pal, PK;  Rodriguez Oroz, MC;  Rodriguez-Violante, M;  Schoels, L;  Stamelou, M;  Tijssen, M;  Uribe Roca, C;  de la Cerda, A;  Gatto, EM;   - view fewer <#>    (2017)    Treatable Inherited Rare Movement Disorders.                   Movement Disorders , 33  (1)   pp. 21-35.    10.1002/mds.27140 <https://doi.org/10.1002/mds.27140>.      
 
document_url: https://discovery.ucl.ac.uk/id/eprint/10032311/1/Bhatia%20Jinnah_et_al-2018-Movement_Disorders.pdf